Clinical Trial

TCP-600 Supplementation and Performance Response in Professional Football Players

Study acronym: TCP600-RESP
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study will examine whether a 28-day supplementation protocol containing taurine, caffeine, and phosphatidylserine can help professional male football players maintain physical performance, cognitive function, recovery-related readiness, and selected football-specific perceptual-cognitive performance. Participants will be randomly assigned to receive either placebo or a phosphatidylserine-containing multi-ingredient supplement. Before and after the supplementation period, players will complete non-invasive assessments such as sprint testing, reaction-time testing, heart rate variability monitoring, wellness/readiness questionnaires, mental-fatigue measures, and selected football-specific perceptual-cognitive tasks where available. The study is designed as an external validation and extension of responder profiles derived from previous randomized controlled trials. Data from previous trials and this validation cohort will be used to examine whether baseline physical, cognitive, autonomic, fatigue-related, recovery-related, or perceptual-cognitive characteristics can predict which players are most likely to benefit from phosphatidylserine-containing multi-ingredient supplementation.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-08-14
critical Primary endpoint(s) modified 2026-07-22
minor Completion pushed: 2026-08 -> 2026-09 2026-07-22
Trial Details
NCT Number NCT07710547
Lead Sponsor Vizja University in Warsaw
Conditions Athletic Performance, Cognitive Fatigue, Exercise Recovery, Football-Specific Performance, Perceptual-cognitive Performance
Enrollment 65 participants
Start Date 2026-08-06
Primary Completion 2026-08-10 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-13